Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

A-PRF

PreclinicalBiologic

KKing Abdulaziz University

4

Indications

5

Total Trials

2

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Impact MolarActive, not recruiting

ExposureActive, not recruiting

HemostasisUnknown status

Impact MolarPreclinical

Active, not recruiting

ExposurePreclinical

Active, not recruiting

HemostasisPreclinical

Unknown status

Timeline

Expected Milestones

Q4 2026

PreclinicalActive, not recruiting

Exposure

NCT07364890

Q2 2027

PreclinicalActive, not recruiting

Impact Molar

NCT07652216

Clinical

Trials by Indication[1]

Surgical1 trial

Pinhole Surgical Technique for Root Coverage Using PRF

Unknown status·KKrishnadevaraya College of Dental Sciences & Hospital·Phase 2·NCT04202198·20 enrolled

Hemostasis1 trial

Comparison of A-PRF vs Bone Wax in Hemostasis, Pain Relief and Healing Following Exodontia

Unknown status·—·N/A·NCT05744726·129 enrolled

Growth Factor1 trial

Comparison of Growth Factor Releases and Degradation Rates of Membranes Obtained From A-PRF+, L-PRF, and Alb-PRF

Completed·IIzmir Katip Celebi University·Preclinical·NCT07778160·10 enrolled

Exposure1 trial

Platelet-Derived Growth Factors to Enhance Healing and Reduce Post-Extraction Complications in Smokers

Active, not recruiting·KKing Abdulaziz University·Preclinical·NCT07364890·12 enrolled

Impact Molar1 trial

Bone Defects Reconstruction After Dentigerous Cyst Enucleation With Autogenous Demineralized Dentin Matrix- ADDM and Advanced Platelet-Rich Fibrin- A-PRF.

Active, not recruiting·JJagiellonian University·Preclinical·NCT07652216·35 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for A-PRF. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — A-PRF compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for A-PRF. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — King Abdulaziz University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: KKing Abdulaziz University

Related News